Related Experiment Videos
T-cell markers in breast cancer patients at diagnosis
Clinical Immunology and Immunopathology
|April 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.
The American journal of the medical sciences·1989
Generation of phenotypically distinct macrophage-hepatoma hybrid clones.
Immunobiology·1987
An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
Clinical immunology and immunopathology·1987
D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.
Clinical immunology and immunopathology·1998
Characterization of gastric Na+/I- symporter of the rat.
Clinical immunology and immunopathology·1998
CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.
Clinical immunology and immunopathology·1998
Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.
Clinical immunology and immunopathology·1998
Somatic hypermutation in T-independent and T-dependent immune responses to Haemophilus influenzae type b polysaccharide.
Clinical immunology and immunopathology·1998
Treatment with progesterone analogues decreases macrophage Fcgamma receptors expression.
Clinical immunology and immunopathology·1998
miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.
Translational cancer research·2026
How cholecystectomy and gastrectomy contribute to pancreatic cancer development: a review.
Annals of medicine and surgery (2012)·2026
Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels.
Translational cancer research·2026